CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Pharmacelera has developed PharmScreen2, a software tool that enhances drug discovery by predicting molecular properties more accurately. This innovation aims to reduce costs and increase the success rate of new drug candidates by providing a comprehensive analysis of their characteristics.
Drug discovery & development projects are long processes that take approximately 15 years from the moment a moleculartarget is discovered to its market launch.
During the past two decades, the costs of new drug development has increasedfrom €1 billion in 2000 to €2.58 billion in 2015.The increase is due in part to the difficulty to find New Molecular Entities (NME) subject to be patented.
Computer-aideddrug design (CADD) tools are used to perform virtual screening, design and the optimization of…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
